↓ Skip to main content

Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy

Overview of attention for article published in Journal of Pharmaceutical Health Care and Sciences, March 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy
Published in
Journal of Pharmaceutical Health Care and Sciences, March 2022
DOI 10.1186/s40780-022-00239-w
Pubmed ID
Authors

Hironori Fujii, Yukino Ueda, Chiemi Hirose, Koichi Ohata, Kumiko Sekiya, Mika Kitahora, Shiori Sadaka, Senri Yamamoto, Daichi Watanabe, Hiroko Kato-Hayashi, Hirotoshi Iihara, Ryo Kobayashi, Miho Kaburaki, Nobuhisa Matsuhashi, Takao Takahashi, Akitaka Makiyama, Kazuhiro Yoshida, Hideki Hayashi, Akio Suzuki

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 20%
Student > Ph. D. Student 2 8%
Researcher 2 8%
Student > Master 2 8%
Other 1 4%
Other 0 0%
Unknown 13 52%
Readers by discipline Count As %
Nursing and Health Professions 5 20%
Pharmacology, Toxicology and Pharmaceutical Science 4 16%
Medicine and Dentistry 2 8%
Computer Science 1 4%
Engineering 1 4%
Other 0 0%
Unknown 12 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2023.
All research outputs
#16,831,622
of 24,749,767 outputs
Outputs from Journal of Pharmaceutical Health Care and Sciences
#67
of 147 outputs
Outputs of similar age
#259,974
of 435,136 outputs
Outputs of similar age from Journal of Pharmaceutical Health Care and Sciences
#2
of 6 outputs
Altmetric has tracked 24,749,767 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 147 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,136 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.